Zobrazeno 1 - 10
of 145
pro vyhledávání: '"Bela, Balint"'
Autor:
Milena Todorović Balint, Nikola Lemajić, Vladimir Jurišić, Sofija Pantelić, Dejana Stanisavljević, Nada Kraguljac Kurtović, Bela Balint
Publikováno v:
Translational Oncology, Vol 39, Iss , Pp 101811- (2024)
Background: Plerixafor is a bicyclam molecule with the ability to reversibly bind to receptor CXCR-4 thus leading to an increased release of stem cells (SC) into the circulation. This study aims to evaluate the efficacy of G-CSF plus plerixafor versu
Externí odkaz:
https://doaj.org/article/06e3a603bc8147d6bef3a6ae7f75d777
Publikováno v:
Current Pharmaceutical Design. 29:555-558
Autor:
Milena Todorovic-Balint, Bela Balint, Irena Djunic, Nevena Besevic, Andrej Pesic, Oliver Stojkovic
Publikováno v:
Medical review. 75:45-49
Introduction. Poor graft function is one of the most severe complications after allogeneic hematopoietic stem cell transplantation, which manifests as pancytopenia/cytopenia in the blood count, with the presence of complete or incomplete donor chimer
Publikováno v:
Srpski medicinski casopis Lekarske komore. 3:135-148
Conventional hematopoietic stem cell transplantation is a well-known treatment method for numerous acquired and congenital hematopoietic disorders, disorders of the immune system, as well as certain metabolic disorders. Stem cells (SCs) can be define
Publikováno v:
Vojnosanitetski pregled. 79:878-882
Background/Aim. After the introduction of a careful selection procedure for blood donors and the implementation of highly sensitive screening tests for transfusion-transmitted infections (TTIs), blood has become a very safe product concerning TTIs. H
Publikováno v:
Scripta Medica, Vol 52, Iss 1, Pp 1-5 (2021)
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a new human disease. December 31, 2019 marked the day the World Health Organization (WHO) first became aware of an infectious outbreak in
Autor:
Farra El Amir, Ivana Urosevic, Aleksandar Savic, Marina Dokic, Ivana Milosevic, Nada Vlaisavljevic, Bela Balint, Marina Dragicevic-Jojkic, Borivoj Sekulic, Ivanka Percic
Publikováno v:
Vojnosanitetski Pregled, Vol 78, Iss 5, Pp 526-531 (2021)
Background/Aim. The treatment of chronic myeloid leukemia (CML) has changed dramatically with the advent of targeted therapies. This study aimed to assess the efficacy of generic imatinib in CML patients treated in our center. Methods. The study was
Autor:
Predrag Krstić, Marija Elez, Biljana Živanović-Todorić, Gordana Ostojić, Bela Balint, Milomir Malešević, Dragana Stamatović
Publikováno v:
Serbian Journal of Experimental and Clinical Research.
Chronic granulocytic leukemia (CGL), Ph + is a chronic myeloproliferative disorder, which, due to its specificity for many decades, has attracted the attention of researchers of specialties. This disease was among the first malignant haemopathies tha
Autor:
Miodrag C. Ostojic, Natalija Arnautovic, Duško Nežic, Tatjana Raguš, Slobodan Micovic, Petar Otasevic, Aleksandra Tomislav Nikolic, Nebojša Tasic, Tamara Kovacevic-Preradovic, Bojan Stanetic, Dragana Unic-Stojanovic, Milan Dobric, Milan Milojevic, Stefan Veljkovic, Nikola N. Boskovic, Dragoljub Djokic, Luka Cucic, Vladimir Mihajlovic, Jelena Kotur Stevuljevic, Ivan Ivanovic, Bela Balint, Sasa Hinic, Snežana Boric, Vlado Djajic, Milovan Bojic
Publikováno v:
Journal of the American College of Cardiology. 81:1155
Autor:
Aleksandar Savic, Bela Balint, Ivana Urosevic, Nebojsa Rajic, Milena Todorovic, Ivanka Percic, Stevan Popovic
Publikováno v:
Turkish Journal of Hematology, Vol 27, Iss 04, Pp 294-298 (2010)
Hepatitis-associated aplastic anemia occurs in up to 10% of all aplastic anemia cases. Syngeneic bone marrow transplantation is rare in patients with severe aplastic anemia and usually requires pre-transplant conditioning to provide engraftment. We r
Externí odkaz:
https://doaj.org/article/9be24aefb0394530887e249c7ce744f1